iX Biopharma (42C) will hold an extraordinary general meeting on Oct. 17 at 11:00 a.m. at its Singapore headquarters, according to a Tuesday filing on the Singapore Exchange.

The meeting will address three resolutions: extending the iX Employee Share Option Scheme (iX ESOS) and the iX Performance Share Plan (iX PSP) for an additional 10 years, until June 16, 2035, and allowing Eddy Lee Yip Hang, a controlling shareholder, to participate in the extended iX PSP.

Both schemes will limit total shares issued to 15% of the company's total issued shares, excluding treasury shares and subsidiary holdings.